Specialists have warned that the approval of a glucagon-like peptide (GLP-1) receptor agonist weight-loss tablet could make it a target for online fraud and counterfeit medicines. Following its introduction into
Pharmaceutical company Merz Aesthetics has received US Food and Drug Administration (FDA) approval for Ultherapy PRIME for skin laxity on the knees. The company shares that this approval on the
The Royal Society of Medicine (RSM) will welcome practitioners to the Aesthetics Congress XIV, taking place on Friday, September 4 in London. The congress theme, ‘Shaping the Future of Aesthetic
Weight-loss injection tirzepatide has been associated with cardioprotective effects, according to new findings. The research, published in The BMJ, set out to estimate the magnitude of reduction in major adverse
Skincare company IMAGE Skincare has released topical formulation VOL.U.LIFT Body designed for weight-loss side effects. Available through aesthetic distributor Wigmore Medical, the new body formula is designed to address the
Skincare company Revision Skincare has released its D·E·J BioStim Treatment Solution designed for in-clinic use. Available through aesthetic distributor AestheticSource, the treatment aims to stimulate the skin’s natural collagen and
Aesthetic distributor Healthxchange has launched its new campaign, designed to highlight standards and principles underpinning medical aesthetics. Healthxchange says its ‘Trust in Aesthetics’ campaign will run across trade and digital
Aesthetic manufacturer Teoxane has announced the launch of male-adapted technique babyGLOW for HIM by Teoxane in the UK. The company explains that the male-adapted skin quality technique is designed specifically
The Anatomy and Complication Management Masterclass – Dalvi Humzah Aesthetic Training took place on July 3 at the Surgical Skills Centre, Coventry. Led by consultant plastic surgeon and anatomist, Mr
Research by aesthetic manufacturer Teoxane highlights growing concern around facial fat loss. Conducted by independent European data collector Norstat on behalf of Teoxane, the research surveyed 2,500 UK participants. A
